HRP20040900B1 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> - Google Patents

Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>

Info

Publication number
HRP20040900B1
HRP20040900B1 HR20040900A HRP20040900A HRP20040900B1 HR P20040900 B1 HRP20040900 B1 HR P20040900B1 HR 20040900 A HR20040900 A HR 20040900A HR P20040900 A HRP20040900 A HR P20040900A HR P20040900 B1 HRP20040900 B1 HR P20040900B1
Authority
HR
Croatia
Prior art keywords
sub
inhibitors
cyclopropylglycinyl
piperidin
certain
Prior art date
Application number
HR20040900A
Other languages
English (en)
Croatian (hr)
Inventor
Robert Wiley Michael
Lowell Engel Gary
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20040900A2 publication Critical patent/HRP20040900A2/xx
Publication of HRP20040900B1 publication Critical patent/HRP20040900B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20040900A 2002-04-01 2004-09-30 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> HRP20040900B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01
PCT/US2003/007794 WO2003084929A1 (en) 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa

Publications (2)

Publication Number Publication Date
HRP20040900A2 HRP20040900A2 (en) 2004-12-31
HRP20040900B1 true HRP20040900B1 (en) 2006-02-28

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040900A HRP20040900B1 (en) 2002-04-01 2004-09-30 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>

Country Status (25)

Country Link
US (1) US7166606B2 (de)
EP (1) EP1492767B1 (de)
JP (1) JP2005531529A (de)
KR (1) KR20040094892A (de)
CN (1) CN1288135C (de)
AT (1) ATE303990T1 (de)
AU (1) AU2003218147A1 (de)
BR (1) BR0308870A (de)
CA (1) CA2478340A1 (de)
CR (1) CR7497A (de)
DE (1) DE60301569T2 (de)
DK (1) DK1492767T3 (de)
EA (1) EA007300B1 (de)
EC (1) ECSP045329A (de)
ES (1) ES2248737T3 (de)
HK (1) HK1070363A1 (de)
HR (1) HRP20040900B1 (de)
IL (1) IL164018A0 (de)
MX (1) MXPA04009640A (de)
NO (1) NO20044688L (de)
NZ (1) NZ535402A (de)
PL (1) PL373066A1 (de)
UA (1) UA76849C2 (de)
WO (1) WO2003084929A1 (de)
ZA (1) ZA200407418B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
EP1490767B1 (de) 2001-04-05 2014-06-11 Audible Magic Corporation Copyright-erkennung und schutzsystem und verfahren
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
WO2018093716A1 (en) * 2016-11-18 2018-05-24 Merck Sharp & Dohme Corp. FACTOR XIIa INHIBITORS
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011658A1 (en) 1997-08-29 1999-03-11 Proteus Molecular Design Ltd. Meta-benzamidine derivatives as serin protease inhibitors
CA2383008A1 (en) 1999-06-14 2000-12-21 Amanda Jane Lyons Compounds
WO2000076971A2 (en) 1999-06-14 2000-12-21 Eli Lilly And Company Serine protease inhibitors
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
AU2002322396A1 (en) * 2001-07-26 2003-02-17 Eli Lilly And Company 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists

Also Published As

Publication number Publication date
NZ535402A (en) 2006-02-24
CA2478340A1 (en) 2003-10-16
EP1492767B1 (de) 2005-09-07
UA76849C2 (uk) 2006-09-15
ECSP045329A (es) 2004-11-26
WO2003084929A1 (en) 2003-10-16
KR20040094892A (ko) 2004-11-10
CR7497A (es) 2005-01-17
DE60301569T2 (de) 2006-06-14
EA200401290A1 (ru) 2005-02-24
ZA200407418B (en) 2005-09-15
DE60301569D1 (de) 2005-10-13
US7166606B2 (en) 2007-01-23
EA007300B1 (ru) 2006-08-25
ES2248737T3 (es) 2006-03-16
DK1492767T3 (da) 2005-11-28
CN1288135C (zh) 2006-12-06
JP2005531529A (ja) 2005-10-20
US20050096328A1 (en) 2005-05-05
BR0308870A (pt) 2005-01-04
IL164018A0 (en) 2005-12-18
AU2003218147A1 (en) 2003-10-20
HK1070363A1 (en) 2005-06-17
NO20044688L (no) 2004-10-29
ATE303990T1 (de) 2005-09-15
CN1642914A (zh) 2005-07-20
WO2003084929A8 (en) 2004-05-21
HRP20040900A2 (en) 2004-12-31
EP1492767A1 (de) 2005-01-05
MXPA04009640A (es) 2005-01-11
PL373066A1 (en) 2005-08-08

Similar Documents

Publication Publication Date Title
WO2005032472A3 (en) Pyrrolidine and piperidine derivatives as factor xa inhibitors
IS7718A (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
HK1091121A1 (en) Substituted 2-aminotetralins for the treatment of depressions
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
RS20050046A (en) 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition
DE60127863D1 (de) Phenylderivate
WO2006047528A3 (en) Pyrazolobenzamides and derivatives as factor xa inhibitors
WO2004031145A3 (en) Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
TW200420545A (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
AU2001264081A1 (en) Serine protease inhibitors
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
MXPA03010205A (es) Derivados de acido oxalico.
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
MY137876A (en) Pharmaceutical compound
DE602005005638D1 (de) 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
WO2003076429A3 (en) Azepane derivatives and their use as atk1 inhibitors
AU2002322396A1 (en) 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
TW200603806A (en) Pharmaceutical compound
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze
MXPA04003477A (es) Sintesis de 4-(piperidil)-(2-piridil)metanona-(e)-o-metiloxima y sales.
TW200519071A (en) 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
AU2002366563A1 (en) Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080304

Year of fee payment: 6

PBON Lapse due to non-payment of renewal fee

Effective date: 20090325